{"id":298422,"date":"2026-10-09T12:54:37","date_gmt":"2026-10-09T07:24:37","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=298422"},"modified":"2026-10-09T12:54:37","modified_gmt":"2026-10-09T07:24:37","slug":"why-beta-drugs-share-price-fall-today-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/why-beta-drugs-share-price-fall-today-2026\/","title":{"rendered":"Beta Drugs (BETA) Share Price Falls 9.03% as Small Cap Slips to Rs 1,726.70"},"content":{"rendered":"
Beta Drugs (BETA)<\/a> share price fell to Rs 1,726.7 today, down 9.03% from the previous close. Market cap was Rs 2,214.69 crore.<\/em><\/div>\n

Beta Drugs Share Price moved lower in today\u2019s trade, with Beta Drugs last traded at Rs 1,726.70 after a 9.03% decline from the previous close of Rs 1,898. The company\u2019s market capitalisation stood at Rs 2,214.69 crore, placing it in the Small Cap category. According to Univest data, the price event is confirmed, but no company-specific catalyst is established. The move matters because the stock had opened above the previous close and then traded through a wide intraday range before settling near the lower end of that band. In today\u2019s Beta Drugs Share Price update, the key question for investors is not only why the share price fell, but also how the company\u2019s valuation, profitability and sector positioning compare with Healthcare peers. Univest data shows a sharp price action day, while the fundamental backdrop remains important for context.<\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n